GlassScriptPhysician profile
Bradley T Marker
NPI 1073717849
$16,750.82
in general payments reported to CMS, 2019-2025
29 companies · $2,238 in 2025
The $2,238 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,815 · 2020: $3,109 · 2021: $418 · 2022: $3,521 · 2023: $2,373 · 2024: $277 · 2025: $2,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $851 · Travel and Lodging: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $850.86 |
| Travel and Lodging | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,184.48 | 2019-2025 | Da Vinci Surgical System |
| Organogenesis INC. | $900.47 | 2019-2024 | Puraply |
| Conmed Corporation | $240.11 | 2021-2025 | Airseal |
| Baxter Healthcare | $231.52 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $161.51 | 2022-2023 | Bracanalysis, Bracanalysis Cdx |
| Allergan, INC. | $144.57 | 2019-2020 | |
| Tela Bio, INC. | $122.46 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $118.92 | 2020-2024 | Integra, Omnigraft, Surgimend |
| W. L. Gore & Associates, INC. | $99.66 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.66 | 2022-2024 | Gattex |
| Angiodynamics, INC. | $56.38 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Smith+Nephew, INC. | $40.06 | 2023-2024 | Collagenase Santyl |
| Kerecis Limited | $39.74 | 2019-2022 | |
| Ethicon US, LLC | $39.03 | 2019 | |
| Davol INC. | $36.98 | 2024 | Phasix Mesh |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $34.44 | 2021 | |
| Depuy Synthes Sales INC. | $33.75 | 2020-2021 | |
| Ossur Americas, INC. | $25.70 | 2025 | |
| Lucid Diagnostics INC. | $25.19 | 2023 | |
| Kci USA, INC. | $21.02 | 2023 | V.A.C. Veraflo, Prevena |
| Csl Behring | $20.06 | 2019 | |
| Z-Medica, LLC | $17.35 | 2019 | |
| Solventum Corporation | $15.43 | 2024 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Prevena |
| Lilly USA, LLC | $15.27 | 2024 | Zepbound |
| Acera Surgical, INC. | $14.61 | 2024 | Restrata Wound Matrix |
| E.R. Squibb & Sons, L.L.C. | $14.44 | 2019 | |
| Cook Medical LLC | $14.10 | 2022 | |
| Tei Biosciences INC | $12.63 | 2019 | |
| Merck Sharp & Dohme LLC | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Marker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.